Patient Care

Orchestra BioMed Announces Appointment of Cardiovascular Device Industry Expert John Mack to Board of Directors

John Mack brings over 30 years of diverse medical device and healthcare technology experience to the Orchestra BioMed Board of…

5 months ago

Myriad Genetics to Release Second Quarter 2024 Financial Results on August 6, 2024

SALT LAKE CITY, July 30, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and…

5 months ago

VitalHub Corp. to Acquire MedCurrent Corporation

TORONTO, July 30, 2024 (GLOBE NEWSWIRE) -- VitalHub Corp. (TSX: VHI) (OTCQX: VHIBF) (the “Company” or “VitalHub”) is pleased to…

5 months ago

AliveDx Announces Turnkey Solution for Precise, Automated Autoimmune Diagnostics

CHICAGO, July 30, 2024 /PRNewswire/ -- AliveDx, a global in vitro diagnostics company that aims to transform patient care, today…

5 months ago

DEEP Launches a Platform to Build Digital Measures of Health

HELSINKI, Finland, July 30, 2024 /PRNewswire/ -- DEEP Measures announces its collaborative platform to build digital measures in clinical trials,…

5 months ago

SOPHiA GENETICS Announces L’hôpital Universitaire Avicenne is Live on SOPHiA DDM™

The hospital will use the SOPHiA DDM™ Platform to enhance its testing and research of blood cancers BOSTON and ROLLE,…

5 months ago

AvaSure to Acquire Ouva’s AI-Powered Smart Room Solutions

Acquisition will expand ambient AI capabilities of AvaSure's Intelligent Virtual Care Platform, driving improvements in patient care and operational efficiency…

5 months ago

HRX 2024 IGNITES INNOVATION FOR CUTTING-EDGE BREAKTHROUGHS IN CARDIOVASCULAR MEDICINE AND DIGITAL HEALTH

Thought leaders, trailblazers, and advocates gather to explore the forefront of discoveries and advance partnerships between medicine and technology. ATLANTA,…

5 months ago

Techsomed Announces U.S. Launch of BioTraceIO Vision and BioTraceIO Precision Software for Image-Guided Ablation Therapy

REHOVOT, Israel, July 29, 2024 /PRNewswire/ -- Techsomed Ltd., a pioneering medical software company, announced today the U.S. launch of…

5 months ago

Interpace Diagnostics® Announces Undefined Extension of Medicare Coverage for PancraGEN®, a Molecular Diagnostic Test That Assesses Cancer Risk of Pancreatic Cysts

PARSIPPANY, NJ, July 29, 2024 (GLOBE NEWSWIRE) -- Interpace Diagnostics®, a subsidiary of Interpace Biosciences®, (“Interpace” or the “Company”) (OTCQX:…

5 months ago